European Journal of Internal Medicine
Volume 19, Issue 5 , Pages 350-355 , July 2008

Efficacy of Raloxifen in treatment of fibromyalgia in menopausal women

  • Shahram Sadreddini

      Affiliations

    • Tabriz University of Medical Sciences, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 9123355170.
    • ,
  • Mahshid Molaeefard

      Affiliations

    • Tehran medical university, Iran
    • Tel.: +98 9126541593.
    • ,
  • Hamid Noshad

      Affiliations

    • Tabriz University of Medical Sciences, Iran
    • Tel.: +98 4115415023.
    • ,
  • Mohamadreza Ardalan

      Affiliations

    • Tabriz University of Medical Sciences, Iran
    • Tel.: +98 9141168518.
    • ,
  • Amirhossein Asadi

      Affiliations

    • Pharmacologist, Sari pharmaceutical university, Iran
    • Tel.: +98 9121404838.

Received 27 April 2007 ,Revised 13 July 2007 ,Accepted 8 October 2007.

References 

  1. Goldenberg DL. Fibromyalgia syndrome: an emerging but controversial condition. JAMA. 1987;257:2782–2787
  2. Bennet RM. Fibromyalgia: the commonest cause of widespread pain. Compr Ther. 1995;21:269–275
  3. Moldofsky H, Searisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbances in patients with fibrositis syndrome and healthy subjects. Psychosom Med. 1975;37:341–351
  4. Moldofsky H. Chronobiological influences on fibromyalgia syndrome: theoretical and therapeutic implications. Ballieres Clin Rheumatol. 1994;8:801–810
  5. Cohen ML, Quintner JL. Fibromyalgia syndrome, a problem of tautology. Lancet. 1993;342:906–909
  6. Benett RM. Confounding features of the fibromyalgia syndrome, a current perspective of differential diagnosis. J Rheumatol. 1989;19:58–61
  7. Wolfe F. The fibromyalgia syndrome: a consensus reports on fibromyalgia and disability. J Rheumatol. 1996;16:185–191
  8. Bohr TW. Fibromyalgia syndrome and myofascial pain syndrome do they really exist?. Neurol Clin. 1995;13:265–284
  9. Wolfe F, Smythe HA, Yunus MB, Bennett RM. The American College of Rheumatology (1990) criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33:160–172
  10. Marder WD, Meenan RF, Felson DT, Reichin M, Birnbaum NS, Croft JD, et al. The present and future adequacy of rheumatology manpower: a study of healthcare needs and physician supply. Arthritis Rheum. 1991;34:1209–1217
  11. MacFarlane GJ, Morris S, Hunt IM, Benjamin S, McBeth J, Papageorgiou AC, et al. Chronic widespread pain in the community: the influence of psychological symptoms and mental disorders on healthcare seeking behaviour. J Rheumatol. 1999;26:413–419
  12. McCain GA, Bell DA, Mai FM, Halliday PD. A controlled study of the effects of a supervised cardiovascular fitness-training program on the manifestations of primary fibromyalgia. Arthritis Rheum. 1988;331:1135–1141
  13. Burckardt CS, Mannerkorpi K, Hedenberg L, Bjelle A. A randomised controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol. 1994;21:714–720
  14. Horven Wigers S, Stiles TC, Vogel PA. Effects of aerobic exercise versus stress management treatment in fibromyalgia. Scand J Rheumatol. 1996;25:77–86
  15. Martin L, Nutting A, Macintosh BR, Edworthy SM, Butterwick D, Cook J. An exercise program in the treatment of fibromyalgia. J Rheumatol. 1996;23:1050–1053
  16. Bandura A. Self efficacy mechanism in physiological activation and health promotion. In: Madden J, Matthysse S, Barchas J, editors. Adoption Learning and Affect. New York: Raven Press; 1991.
  17. Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum. 1989;32:37–44
  18. Yunus M, Masi AT, Aldag JC. Short term benefits of ibuprofen in primary fibromyalgia syndrome: a double blind placebo controlled trial. J Rheumatol. 1989;16:527–532
  19. Goldenberg DL, Felson DT, Dinerman H. A randomised controlled trial of amytriptyline and naproxen in the treatment of fibromyalgia syndrome. Arthritis Rheum. 1986;29:1371–1377
  20. Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res. 1998;8:13–19
  21. Carrette S, Mccain GA, Bell DA, Fam AG. Evaluation of amitriptyline in fibrositis: a double blind placebo controlled study. Arthritis Rheum. 1986;29:655–659
  22. Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol. 1991;18:447–451
  23. Barnes CD, Fung SJ, Gintautus J. Brainstem noradrenergic system depression by cyclobenzaprine. Neuropharmacology. 1980;19:221–224
  24. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double blind controlled study. Arthritis Rheum. 1988;31:1535–1542
  25. Carrette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, et al. Comparison of cyclobenzaprine, amitriptyline and placebo in fibromyalgia: a randomised double blind clinical trial. Arthritis Rheum. 1994;37:32–40
  26. Cortet B, Houvenagel E, Forzy G, Vincent G, Delcambre B. Evaluation of the effectiveness of serotonin (fluoxetine hydrochloride) treatment. Open study in fibromyalgia. Rev Rhum Mal Osteo-artic. 1992;59:497–500
  27. Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994;23:255–259
  28. Vercoulen JH, Swanink CM, Zitman FG, Vreden SG, Hoofs MP, Fennis JF, et al. Randomised double blind placebo controlled study of fluoxetine in chronic fatigue syndrome. Lancet. 1996;347:8858–8861
  29. Baraczka K, Janko Z, Vargha K, Markus H. Clinical experiences with the analgesic effects of citalopram. Orv Hetil. 1997;138:2605–2607
  30. Norregaard J, Volkmann H, Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain. 1995;61:445–449
  31. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39:1852–1859
  32. Berman BM, Ezzo J, Hadhazy V, Swyers JP. Is acupuncture effective in the treatment of fibromyalgia?. J Fam Pract. 1999;48:213–218
  33. Haanen HC, Hoenderos HT, Van Romunde LK, Hop WC. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol. 1991;1:72–75
  34. Nicassio PM, Schuman C, Kim J, Cordova C, Weisman M. Psychosocial factors associated with complementary treatment use in fibromyalgia. J Rheumatol. 1997;24:2008–2013
  35. Nina HB. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women. Dan Med Bull. 2005;52:64–81
  36. Delmas P, Bruce H, Anne-Catherine R, Ravoux AC, Shah AS, Huster WJ, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med. 1997;337:1641–1647
  37. Yaping Ji, Anne ZM, Richard JT. Estrogen modulates the visceromotor reflex and responses of spinal dorsal horn neurons to colorectal stimulation in the rat. J Neurosci. 2003;23(9):3908
  38. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137–145
  39. Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The hospital anxiety and depression scale (HAD), translation and validation study of the Iranian version. Health Qual of Life Outcomes. 2003;1:14
  40. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res. 1997;42:17–41
  41. Bjelland I, Dahl AA, Tangen Haug T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69–77
  42. Baumgartner E, Finckh A, Cedraschi C, Vischer TL. A six-year prospective study of a cohort of patients with fibromyalgia. Ann Rheum Dis. 2002;61:644–645
  43. Pioro-Boisset M, Esdaile JM, Fitzcharles MA. Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res. 1996;9:13–17

PII: S0953-6205(07)00295-6

doi: 10.1016/j.ejim.2007.10.006

European Journal of Internal Medicine
Volume 19, Issue 5 , Pages 350-355 , July 2008

Article Tools

* Image Usage & Resolution